By combining antibody engineering and in vivo imaging techniques, we can visualize and quantify tissue targeting, delivery, processing and therapeutic events.

Disease Models

We have developed stringent pre-clinical tumor and fibrotic lung models that more faithfully replicate human disease and allow us to dynamically image molecular transport of targeted therapeutic agents at high resolution to monitor progression and response to treatment in exquisite detail.   

Opportunity

Our delivery platforms can provide a significant improvement to penetration of drugs, including ADCs and nanoparticles, resulting in vastly improved therapeutic provides and minimal toxicities.